Wayne A. Marasco, MD, PhD

Publications

• Han T, Marasco WA.Structural basis of influenza virus neutralization.Ann N Y Acad Sci. 2011 Jan;1217:178-90. Review.
  21251008
• Kuan CT, Srivastava N, McLendon RE, Marasco WA, Zalutsky MR, Bigner DD.Recombinant single-chain variable fragment antibodies against extracellular epitopes of human multidrug resistance protein MRP3 for targeting malignant gliomas.Int J Cancer. 2010 Aug 1
  19937796
• Xu C, Lo A, Yammanuru A, Tallarico AS, Brady K, Murakami A, Barteneva N, Zhu Q, Marasco WA.Unique biological properties of catalytic domain directed human anti-CAIX antibodies discovered through phage-display technology.PLoS ONE. 2010;5(3):e9625.
  20224781
• Nakase K,Cheng J,Zhu Q,Marasco WA.Mechanisms of SHP-1 P2 promoter regulation in hematopoietic cells and its silencing in HTLV-1-transformed T cells.J Leukoc Biol. 2009 Jan;85(1):165-74.
  18948549
• Taube R,Zhu Q,Xu C,Diaz-Griffero F,Sui J,Kamau E,Dwyer M,Aird D,Marasco WA.Lentivirus display: stable expression of human antibodies on the surface of human cells and virus particles.PLoS ONE. 2008;3(9):e3181.
  18784843
• Lo AS, Zhu Q, Marasco WA.Intracellular antibodies (intrabodies) and their therapeutic potential.Handb Exp Pharmacol. 2008(181):343-73. Review.
  18071953
• Marasco WA, Sui J.The growth and potential of human antiviral monoclonal antibody therapeutics.Nat Biotechnol. 2007 Dec;25(12):1421-34. Review.
  18066039
• Cheng J, Kydd AR, Nakase K, Noonan KM, Murakami A, Tao H, Dwyer M, Xu C, Zhu Q, Marasco WA.Negative regulation of the SH2-homology-containing protein-tyrosine phosphatase-1 (SHP-1) P2 promoter by the HTLV-1 tax oncoprotein.Blood. 2007 Sep 15;110(6):2110-2
  17540846
• Xu C, Sui J, Tao H, Zhu Q, Marasco WA.Human anti-CXCR4 antibodies undergo VH replacement, exhibit functional V-region sulfation, and define CXCR4 antigenic heterogeneity.J Immunol. 2007 Aug 15;179(4):2408-18.
  17675502
• Li W, Sui J, Huang IC, Kuhn JH, Radoshitzky SR, Marasco WA, Choe H, Farzan M.The S proteins of human coronavirus NL63 and severe acute respiratory syndrome coronavirus bind overlapping regions of ACE2.Virology. 2007 Oct 25;367(2):367-74.
  17631932
• Hwang WC, Lin Y, Santelli E, Sui J, Jaroszewski L, Stec B, Farzan M, Marasco WA, Liddington RC.Structural basis of neutralization by a human anti-severe acute respiratory syndrome spike protein antibody, 80R.J Biol Chem. 2006 Nov 10;281(45):34610-6.
  16954221
• Kanai R, Kar K, Anthony K, Gould LH, Ledizet M, Fikrig E, Marasco WA, Koski RA, Modis Y.Crystal structure of west nile virus envelope glycoprotein reveals viral surface epitopes.J Virol. 2006 Nov;80(22):11000-8.
  16943291
• Yuan QA, Simmons HH, Robinson MK, Russeva M, Marasco WA, Adams GP.Development of engineered antibodies specific for the Müllerian inhibiting substance type II receptor: a promising candidate for targeted therapy of ovarian cancer.Mol Cancer Ther. 2006 Aug
  16928831
• Bai J, Demirjian A, Sui J, Marasco W, Callery MP.Histone deacetylase inhibitor trichostatin A and proteasome inhibitor PS-341 synergistically induce apoptosis in pancreatic cancer cells.Biochem Biophys Res Commun. 2006 Oct 6;348(4):1245-53.
  16904634
• Si Z, Vandegraaff N, O'huigin C, Song B, Yuan W, Xu C, Perron M, Li X, Marasco WA, Engelman A, Dean M, Sodroski J.Evolution of a cytoplasmic tripartite motif (TRIM) protein in cows that restricts retroviral infection.Proc Natl Acad Sci U S A. 2006 Ma
  16648259
• Tarnovitski N, Matthews LJ, Sui J, Gershoni JM, Marasco WA.Mapping a Neutralizing Epitope on the SARS Coronavirus Spike Protein: Computational Prediction Based on Affinity-selected Peptides.J Mol Biol. 2006 May 26;359(1):190-201.
  16630634
• Gould LH, Sui J, Foellmer H, Oliphant T, Wang T, Ledizet M, Murakami A, Noonan K, Lambeth C, Kar K, Anderson JF, de Silva AM, Diamond MS, Koski RA, Marasco WA, Fikrig E.Protective and therapeutic capacity of human single-chain Fv-Fc fusion proteins agains
  16282460
• Song E, Zhu P, Lee SK, Chowdhury D, Kussman S, Dykxhoorn DM, Feng Y, Palliser D, Weiner DB, Shankar P, Marasco WA, Lieberman J.Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors.Nat Biotechnol. 2005 Jun;23(6):709-17.
  15908939
• Bal HP, Cheng J, Murakami A, Tallarico AS, Wang W, Zhou D, Vasicek TJ, Marasco WA.GITR overexpression on CD4+CD25+ HTLV-1 transformed cells: detection by massively parallel signature sequencing.Biochem Biophys Res Commun. 2005 Jul 1;332(2):569-84.
  15896717
• Qin C, Wang J, Wei Q, She M, Marasco WA, Jiang H, Tu X, Zhu H, Ren L, Gao H, Guo L, Huang L, Yang R, Cong Z, Guo L, Wang Y, Liu Y, Sun Y, Duan S, Qu J, Chen L, Tong W, Ruan L, Liu P, Zhang H, Zhang J, Zhang H, Liu D, Liu Q, Hong T, He W.An animal model of
  15892035
• Marasco WA.Therapeutic antibody gene transfer.Nat Biotechnol. 2005 May;23(5):551-2.
  15877069
• Sui J, Li W, Roberts A, Matthews LJ, Murakami A, Vogel L, Wong SK, Subbarao K, Farzan M, Marasco WA.Evaluation of human monoclonal antibody 80R for immunoprophylaxis of severe acute respiratory syndrome by an animal study, epitope mapping, and analysis of
  15857975
• Li W, Zhang C, Sui J, Kuhn JH, Moore MJ, Luo S, Wong SK, Huang IC, Xu K, Vasilieva N, Murakami A, He Y, Marasco WA, Guan Y, Choe H, Farzan M.Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2.EMBO J. 2005 Apr 20;24(8):1634-43.
  15791205
• Bai J, Sui J, Demirjian A, Vollmer CM, Marasco W, Callery MP.Predominant Bcl-XL knockdown disables antiapoptotic mechanisms: tumor necrosis factor-related apoptosis-inducing ligand-based triple chemotherapy overcomes chemoresistance in pancreatic cancer c
  15781649
• Masiero S, Del Vecchio C, Gavioli R, Mattiuzzo G, Cusi MG, Micheli L, Gennari F, Siccardi A, Marasco WA, Palù G, Parolin C.T-cell engineering by a chimeric T-cell receptor with antibody-type specificity for the HIV-1 gp120.Gene Ther. 2005 Feb;12(4):299-31
  15496956
• Busch A, Marasco WA, Doebis C, Volk HD, Seifert M.MHC class I manipulation on cell surfaces by gene transfer of anti-MHC class I intrabodies--a tool for decreased immunogenicity of allogeneic tissue and cell transplants.Methods. 2004 Oct;34(2):240-9.
  15312677
• Beyer F, Doebis C, Busch A, Ritter T, Mhashilkar A, Marasco WM, Laube H, Volk HD, Seifert M.Decline of surface MHC I by adenoviral gene transfer of anti-MHC I intrabodies in human endothelial cells-new perspectives for the generation of universal donor ce
  15170732
• Sui J, Li W, Murakami A, Tamin A, Matthews LJ, Wong SK, Moore MJ, Tallarico AS, Olurinde M, Choe H, Anderson LJ, Bellini WJ, Farzan M, Marasco WA.Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein th
  14983044
• Gennari F, Mehta S, Wang Y, St Clair Tallarico A, Palu G, Marasco WA.Direct phage to intrabody screening (DPIS): demonstration by isolation of cytosolic intrabodies against the TES1 site of Epstein Barr virus latent membrane protein 1 (LMP1) that block N
  14659750
• Cheng J, Zhang D, Zhou C, Marasco WA.Down-regulation of SHP1 and up-regulation of negative regulators of JAK/STAT signaling in HTLV-1 transformed cell lines and freshly transformed human peripheral blood CD4+ T-cells.Leuk Res. 2004 Jan;28(1):71-82.
  14630083
• Sui J, Bai J, St Clair Tallarico A, Xu C, Marasco WA.Identification of CD4 and transferrin receptor antibodies by CXCR4 antibody-guided Pathfinder selection.Eur J Biochem. 2003 Nov;270(22):4497-506.
  14622278
• Zhang D, Murakami A, Johnson RP, Sui J, Cheng J, Bai J, Marasco WA.Optimization of ex vivo activation and expansion of macaque primary CD4-enriched peripheral blood mononuclear cells for use in anti-HIV immunotherapy and gene therapy strategies.J Acquir I
  12626883
• Sui J, Marasco WA.Evidence against Ebola virus sGP binding to human neutrophils by a specific receptor.Virology. 2002 Nov 10;303(1):9-14.
  12482654
• Bai J, Sui J, Zhu RY, Tallarico AS, Gennari F, Zhang D, Marasco WA.Inhibition of Tat-mediated transactivation and HIV-1 replication by human anti-hCyclinT1 intrabodies.J Biol Chem. 2003 Jan 17;278(3):1433-42.
  12401780
• Mhashilkar AM, Doebis C, Seifert M, Busch A, Zani C, Soo Hoo J, Nagy M, Ritter T, Volk HD, Marasco WA.Intrabody-mediated phenotypic knockout of major histocompatibility complex class I expression in human and monkey cell lines and in primary human keratin
  11938450
• Ogueta SB, Yao F, Marasco WA.Design and in vitro characterization of a single regulatory module for efficient control of gene expression in both plasmid DNA and a self-inactivating lentiviral vector.Mol Med. 2001 Aug;7(8):569-79.
  11591893
• Li X, Stuckert P, Bosch I, Marks JD, Marasco WA.Single-chain antibody-mediated gene delivery into ErbB2-positive human breast cancer cells.Cancer Gene Ther. 2001 Aug;8(8):555-65.
  11571533
• Li X, Josef J, Marasco WA.Hiv-1 Tat can substantially enhance the capacity of NIK to induce IkappaB degradation.Biochem Biophys Res Commun. 2001 Aug 24;286(3):587-94.
  11511100
• Marasco WA.Intrabodies as antiviral agents.Curr Top Microbiol Immunol. 2001;260:247-70.
  11443877
• Li X, Multon MC, Henin Y, Schweighoffer F, Venot C, LaVecchio J, Josef J, Stuckert P, Mhashilkar A, Tocqué B, Marasco WA.Upregulation of the apoptosis-associated protein Grb3-3 in HIV-1-infected human CD4(+) lymphocytes.Biochem Biophys Res Commun. 2000 Se
  11006130
• Li X, Multon MC, Henin Y, Schweighoffer F, Venot C, Josef J, Zhou C, LaVecchio J, Stuckert P, Raab M, Mhashilkar A, Tocque B, Marasco WA.Grb3-3 is up-regulated in HIV-1-infected T-cells and can potentiate cell activation through NFATc.J Biol Chem. 2000 Oc
  10906142
• Marasco WA, Dana Jones S.Antibodies for targeted gene therapy: extracellular gene targeting and intracellular expression.Adv Drug Deliv Rev. 1998 Apr 6;31(1-2):153-170.
  10837623
• Mirzabekov T, Kontos H, Farzan M, Marasco W, Sodroski J.Paramagnetic proteoliposomes containing a pure, native, and oriented seven-transmembrane segment protein, CCR5.Nat Biotechnol. 2000 Jun;18(6):649-54.
  10835604
• Marasco WA, LaVecchio J, Winkler A.Human anti-HIV-1 tat sFv intrabodies for gene therapy of advanced HIV-1-infection and AIDS.J Immunol Methods. 1999 Dec 10;231(1-2):223-38.
  10648940
• Zhu Q, Zeng C, Huhalov A, Yao J, Turi TG, Danley D, Hynes T, Cong Y, DiMattia D, Kennedy S, Daumy G, Schaeffer E, Marasco WA, Huston JS.Extended half-life and elevated steady-state level of a single-chain Fv intrabody are critical for specific intracellul
  10648939
• Song SU, Marasco WA.Rapid establishment of myeloma cell lines expressing Fab(Tac)-protamine, a targetable protein vector, directed against high-affinity alpha-chain of human interleukin-2 receptor.Methods Mol Biol. 2000;133:157-66.
  10561837
• Poznansky MC, La Vecchio J, Silva-Arietta S, Porter-Brooks J, Brody K, Olszak IT, Adams GB, Ramstedt U, Marasco WA, Scadden DT.Inhibition of human immunodeficiency virus replication and growth advantage of CD4+ T cells and monocytes derived from CD34+ cel
  10543615
• Mhashilkar AM, LaVecchio J, Eberhardt B, Porter-Brooks J, Boisot S, Dove JH, Pumphrey C, Li X, Weissmahr RN, Ring DB, Ramstedt U, Marasco WA.Inhibition of human immunodeficiency virus type 1 replication in vitro in acutely and persistently infected human
  10395371
• Richardson JH, Hofmann W, Sodroski JG, Marasco WA.Intrabody-mediated knockout of the high-affinity IL-2 receptor in primary human T cells using a bicistronic lentivirus vector.Gene Ther. 1998 May;5(5):635-44.
  9797868
• Marasco WA, Chen S, Richardson JH, Ramstedt U, Jones SD.Intracellular antibodies against HIV-1 envelope protein for AIDS gene therapy.Hum Gene Ther. 1998 Jul 20;9(11):1627-42.
  9694161
• Poznansky MC, Foxall R, Mhashilkar A, Coker R, Jones S, Ramstedt U, Marasco W.Inhibition of human immunodeficiency virus replication and growth advantage of CD4+ T cells from HIV-infected individuals that express intracellular antibodies against HIV-1 gp1
  9525310
• Vallat AV, De Girolami U, He J, Mhashilkar A, Marasco W, Shi B, Gray F, Bell J, Keohane C, Smith TW, Gabuzda D.Localization of HIV-1 co-receptors CCR5 and CXCR4 in the brain of children with AIDS.Am J Pathol. 1998 Jan;152(1):167-78.
  9422534
• Marasco WA.Intracellular antibodies (intrabodies) as research reagents and therapeutic molecules for gene therapy.Immunotechnology. 1995 May;1(1):1-19.
  9373329
• Richardson JH, Waldmann TA, Sodroski JG, Marasco WA.Inducible knockout of the interleukin-2 receptor alpha chain: expression of the high-affinity IL-2 receptor is not required for the in vitro growth of HTLV-I-transformed cell lines.Virology. 1997 Oct 27;
  9356333
• Rondon IJ, Marasco WA.Intracellular antibodies (intrabodies) for gene therapy of infectious diseases.Annu Rev Microbiol. 1997;51:257-83.
  9343351
• Mhashilkar AM, Biswas DK, LaVecchio J, Pardee AB, Marasco WA.Inhibition of human immunodeficiency virus type 1 replication in vitro by a novel combination of anti-Tat single-chain intrabodies and NF-kappa B antagonists.J Virol. 1997 Sep;71(9):6486-94.
  9261367
• Levin R, Mhashilkar AM, Dorfman T, Bukovsky A, Zani C, Bagley J, Hinkula J, Niedrig M, Albert J, Wahren B, Göttlinger HG, Marasco WA.Inhibition of early and late events of the HIV-1 replication cycle by cytoplasmic Fab intrabodies against the matrix prote
  9085253
• Marasco WA.Intrabodies: turning the humoral immune system outside in for intracellular immunization.Gene Ther. 1997 Jan;4(1):11-5.
  9068790
• Chen JD, Yang Q, Yang AG, Marasco WA, Chen SY.Intra- and extracellular immunization against HIV-1 infection with lymphocytes transduced with an AAV vector expressing a human anti-gp120 antibody.Hum Gene Ther. 1996 Aug 20;7(13):1515-25.
  8864752
• Chen SY, Marasco WA.Novel genetic immunotoxins and intracellular antibodies for cancer therapy.Semin Oncol. 1996 Feb;23(1):148-53.
  8607024
• Richardson JH, Marasco WA.Intracellular antibodies: development and therapeutic potential.Trends Biotechnol. 1995 Aug;13(8):306-10.
  7662306
• Richardson JH, Sodroski JG, Waldmann TA, Marasco WA.Phenotypic knockout of the high-affinity human interleukin 2 receptor by intracellular single-chain antibodies against the alpha subunit of the receptor.Proc Natl Acad Sci U S A. 1995 Apr 11;92(8):3137-4
  7724529
• Mhashilkar AM, Bagley J, Chen SY, Szilvay AM, Helland DG, Marasco WA.Inhibition of HIV-1 Tat-mediated LTR transactivation and HIV-1 infection by anti-Tat single chain intrabodies.EMBO J. 1995 Apr 3;14(7):1542-51.
  7537216
• Chen SY, Zani C, Khouri Y, Marasco WA.Design of a genetic immunotoxin to eliminate toxin immunogenicity.Gene Ther. 1995 Mar;2(2):116-23.
  7719928
• Khouri YF, McIntosh K, Cavacini L, Posner M, Pagano M, Tuomala R, Marasco WA.Vertical Transmission of HIV-1. Correlation with maternal viral load and plasma levels of CD4 binding site anti-gp120 antibodies.J Clin Invest. 1995 Feb;95(2):732-7.
  7860754
• Bagley J, Dillon PJ, Rosen C, Robinson J, Sodroski J, Marasco WA.Structural characterization of broadly neutralizing human monoclonal antibodies against the CD4 binding site of HIV-1 gp120.Mol Immunol. 1994 Oct;31(15):1149-60.
  7935503
• Chen SY, Khouri Y, Bagley J, Marasco WA.Combined intra- and extracellular immunization against human immunodeficiency virus type 1 infection with a human anti-gp120 antibody.Proc Natl Acad Sci U S A. 1994 Jun 21;91(13):5932-6.
  8016092
• Chen SY, Bagley J, Marasco WA.Intracellular antibodies as a new class of therapeutic molecules for gene therapy.Hum Gene Ther. 1994 May;5(5):595-601.
  7914435
• Marasco WA, Szilvay AM, Kalland KH, Helland DG, Reyes HM, Walter RJ.Spatial association of HIV-1 tat protein and the nucleolar transport protein B23 in stably transfected Jurkat T-cells.Arch Virol. 1994;139(1-2):133-54.
  7826206
• Marasco WA, Haseltine WA, Chen SY.Design, intracellular expression, and activity of a human anti-human immunodeficiency virus type 1 gp120 single-chain antibody.Proc Natl Acad Sci U S A. 1993 Aug 15;90(16):7889-93.
  8356098
• Marasco WA, Bagley J, Zani C, Posner M, Cavacini L, Haseltine WA, Sodroski J.Characterization of the cDNA of a broadly reactive neutralizing human anti-gp120 monoclonal antibody.J Clin Invest. 1992 Oct;90(4):1467-78.
  1401079
• Garcia LW, Hemphill RB, Marasco WA, Ciano PS.Acquired immunodeficiency syndrome with disseminated toxoplasmosis presenting as an acute pulmonary and gastrointestinal illness.Arch Pathol Lab Med. 1991 May;115(5):459-63.
  2021313
• Bradley SF, Gordon JJ, Baumgartner DD, Marasco WA, Kauffman CA.Group C streptococcal bacteremia: analysis of 88 cases.Rev Infect Dis. 1991 Mar-Apr;13(2):270-80.
  2041960
• Sannomiya P, Craig RA, Clewell DB, Suzuki A, Fujino M, Till GO, Marasco WA.Characterization of a class of nonformylated Enterococcus faecalis-derived neutrophil chemotactic peptides: the sex pheromones.Proc Natl Acad Sci U S A. 1990 Jan;87(1):66-70.
  2104986
• Marasco WA, Lester S, Parsonnet J.Unusual presentation of cat scratch disease in a patient positive for antibody to the human immunodeficiency virus.Rev Infect Dis. 1989 Sep-Oct;11(5):793-803.
  2814165
• Janeczek AH, Marasco WA, van Alten PJ, Walter RJ.Autoradiographic analysis of formylpeptide chemoattractant binding, uptake and intracellular processing by neutrophils.J Cell Sci. 1989 Sep;94 ( Pt 1):155-68.
  2515197
• Feltner DE, Marasco WA.Regulation of formyl peptide receptor binding to rabbit neutrophil plasma membranes. Use of monovalent cations, guanine nucleotides, and bacterial toxins to discriminate among different states of the receptor.J Immunol. 1989 Jun 1;1
  2715641
• Atkinson YH, Lopez AF, Marasco WA, Lucas CM, Wong GG, Burns GF, Vadas MA.Recombinant human granulocyte-macrophage colony-stimulating factor (rH GM-CSF) regulates f Met-Leu-Phe receptors on human neutrophils.Immunology. 1988 Jul;64(3):519-25.
  2842255
• Atkinson YH, Marasco WA, Lopez AF, Vadas MA.Recombinant human tumor necrosis factor-alpha. Regulation of N-formylmethionylleucylphenylalanine receptor affinity and function on human neutrophils.J Clin Invest. 1988 Mar;81(3):759-65.
  2830314
• Marasco WA, Ward PA.Chemotactic factors of bacterial origin.Methods Enzymol. 1988;162:198-214.
  3067051
• Marasco WA, Gikas PW, Azziz-Baumgartner R, Hyzy R, Eldredge CJ, Stross J.Ibuprofen-associated renal dysfunction. Pathophysiologic mechanisms of acute renal failure, hyperkalemia, tubular necrosis, and proteinuria.Arch Intern Med. 1987 Dec;147(12):2107-16.
  3689062
• Walter RJ, Marasco WA.Direct visualization of formylpeptide receptor binding on rounded and polarized human neutrophils: cellular and receptor heterogeneity.J Leukoc Biol. 1987 May;41(5):377-91.
  3553401
• Feltner DE, Smith RH, Marasco WA.Characterization of the plasma membrane bound GTPase from rabbit neutrophils. I. Evidence for an Ni-like protein coupled to the formyl peptide, C5a, and leukotriene B4 chemotaxis receptors.J Immunol. 1986 Sep 15;137(6):196
  3018082
• Duque RE, Fantone JC, Kramer C, Marasco WA, Phan SH.Inhibition of neutrophil activation by p-bromophenacyl bromide and its effects on phospholipase A2.Br J Pharmacol. 1986 Jun;88(2):463-72.
  3015312
• Marasco WA, Becker KM, Feltner DE, Brown CS, Ward PA, Nairn R.Covalent affinity labeling, detergent solubilization, and fluid-phase characterization of the rabbit neutrophil formyl peptide chemotaxis receptor.Biochemistry. 1985 Apr 23;24(9):2227-36.
  3995012
• Marasco WA, Ward PA, Feltner DE, Varani J.Chemotactic factor binding by metastatic tumour cells: evidence for a formyl-peptide receptor on a non-myelogenous cell.J Cell Sci. 1985 Feb;73:121-34.
  4019589
• Marasco WA, Feltner DE, Ward PA.Formyl peptide chemotaxis receptors on the rat neutrophil: experimental evidence for negative cooperativity.J Cell Biochem. 1985;27(4):359-75.
  2987275
• Nairn R, Smith RH, Brown CS, Marasco WA.What are the molecular characteristics of the neutrophil receptor for chemotactic formylated peptides?.Surv Immunol Res. 1985;4(3):213-9.
  3003857
• Walter RJ, Marasco WA.Localization of chemotactic peptide receptors on rabbit neutrophils.Exp Cell Res. 1984 Oct;154(2):613-8.
  6479242
• Marasco WA, Phan SH, Krutzsch H, Showell HJ, Feltner DE, Nairn R, Becker EL, Ward PA.Purification and identification of formyl-methionyl-leucyl-phenylalanine as the major peptide neutrophil chemotactic factor produced by Escherichia coli.J Biol Chem. 1984
  6371005
• Fantone JC, Marasco WA, Elgas LJ, Ward PA.Stimulus specificity of prostaglandin inhibition of rabbit polymorphonuclear leukocyte lysosomal enzyme release and superoxide anion production.Am J Pathol. 1984 Apr;115(1):9-16.
  6324595
• Kunkel SL, Manderino GL, Marasco W, Kaercher K, Hirata AA, Ward PA.A specific enzyme-linked immunosorbent assay (ELISA) for the determination of human C5a antigen.J Immunol Methods. 1983 Sep 16;62(3):305-14.
  6193199
• Marasco WA, Fantone JC, Freer RJ, Ward PA.Characterization of the rat neutrophil formyl peptide chemotaxis receptor.Am J Pathol. 1983 Jun;111(3):273-81.
  6305198
• Fantone JC, Marasco WA, Elgas LJ, Ward PA.Anti-inflammatory effects of prostaglandin E1: in vivo modulation of the formyl peptide chemotactic receptor on the rat neutrophil.J Immunol. 1983 Apr;130(4):1495-7.
  6300229
• Marasco WA, Fantone JC, Ward PA.Spasmogenic activity of chemotactic N-formylated oligopeptides: identity of structure--function relationships for chemotactic and spasmogenic activities.Proc Natl Acad Sci U S A. 1982 Dec;79(23):7470-3.
  6296835
• Marasco WA, Showell HJ, Freer RJ, Becker EL.Anti-f Met-Leu-Phe: similarities in fine specificity with the formyl peptide chemotaxis receptor of the neutrophil.J Immunol. 1982 Feb;128(2):956-62.
  7033385
• Marasco WA, Becker EL.Anti-idiotype as antibody against the formyl peptide chemotaxis receptor of the neutrophil.J Immunol. 1982 Feb;128(2):963-8.
  7054297
• Marasco WA, Showell HJ, Becker EL.Substance P binds to the formylpeptide chemotaxis receptor on the rabbit neutrophil.Biochem Biophys Res Commun. 1981 Apr 30;99(4):1065-72.
  6167265
• Marasco WA, Becker EL, Oliver JM.The ionic basis of chemotaxis. Separate cation requirements for neutrophil orientation and locomotion in a gradient of chemotactic peptide.Am J Pathol. 1980 Mar;98(3):749-68.
  6767408